Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genomics in multiple sclerosis--current state and future directions.

Manuel Comabella1, Roland Martin

  • 1Unitat de Neuroimmunologia Clinica, Institut de Recerca, Hospital Universitari Vall d'Hebron, Barcelona, Spain. mcomabel@ir.vhebron.net

Journal of Neuroimmunology
|April 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing Progression Independent of Relapse Activity in Multiple Sclerosis Using a Patient-Reported Disability Measure and Self-Administered Neuroperformance Outcomes.

Annals of neurology·2026
Same author

Chronological ageing and ovarian reserve in MS: insights from anti-Müllerian hormone and disability progression.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

Proinflammatory Epstein-Barr Virus Antibody Functions Track with Disease Activity in Multiple Sclerosis.

Annals of neurology·2026
Same author

Spider-MS: an individualized polyhedral prediction of multiple sclerosis prognosis.

Brain : a journal of neurology·2026
Same author

Live Attenuated Measles-Mumps-Rubella and Varicella Vaccinations and Multiple Sclerosis Activity.

JAMA network open·2026
Same author

A glial oxidative signature predicts disability in primary progressive multiple sclerosis and is associated with long-term cognitive decline.

Frontiers in immunology·2026

Gene expression profiling using microarrays in multiple sclerosis (MS) and experimental allergic encephalomyelitis (EAE) shows promise but faces skepticism. This review summarizes data, discusses challenges, and suggests future directions for MS research.

Area of Science:

  • Genomics
  • Neuroimmunology
  • Molecular Biology

Background:

  • Microarray technology enables large-scale gene expression profiling.
  • Multiple sclerosis (MS) and its animal model, experimental allergic encephalomyelitis (EAE), are complex diseases.
  • Gene expression profiling studies in MS and EAE have yielded promising but debated results.

Purpose of the Study:

  • To review existing gene expression profiling data in MS and EAE.
  • To discuss the challenges and limitations of microarray-based research in MS.
  • To propose future directions for utilizing microarrays in multiple sclerosis research.

Main Methods:

  • Comprehensive literature review of microarray studies in MS and EAE.
  • Analysis of existing gene expression datasets.

Related Experiment Videos

  • Discussion of methodological and analytical challenges.

    • Main Results:

    • Gene expression profiling offers insights into MS and EAE pathogenesis.
    • Significant variability exists between studies due to technical and analytical issues.
    • Skepticism surrounds microarray data due to concerns about reproducibility and interpretation.

    Conclusions:

    • Microarray technology holds potential for advancing MS research.
    • Addressing technical reproducibility and data analysis strategies is crucial.
    • Future research should focus on robust methodologies for reliable gene expression profiling in MS.